Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Vildagliptin Tablets

Approval Number

国药准字H20223334

Company康普药业股份有限公司

Registration Date

May 25, 2022

Drug Information

Generic Name

维格列汀片

Dosage Form

片剂

Strength

50mg

Drug Type

化学药品

Registration Date

May 25, 2022

Company Information

Applicant Company

Company Name康普药业股份有限公司

Company Address

湖南省常德市汉寿县高新产业园康普大道8号

Manufacturing Company

Company Name康普药业股份有限公司

Company Address

湖南省汉寿太子庙工业园康普大道8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

维格列汀片 - NMPA 批准文号 | MedPath